Australia markets closed

Assembly Biosciences, Inc. (ASMB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.30-0.08 (-0.60%)
At close: 04:00PM EDT
13.00 -0.30 (-2.26%)
After hours: 04:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close13.38
Open13.15
Bid12.75 x 300
Ask12.95 x 800
Day's range13.02 - 13.45
52-week range7.68 - 20.04
Volume30,110
Avg. volume29,717
Market cap72.921M
Beta (5Y monthly)0.57
PE ratio (TTM)N/A
EPS (TTM)-17.16
Earnings date02 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est36.00
  • GlobeNewswire

    Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights

    Four candidates planned to be in clinical development in 2024 with interim data from two studies anticipated by year end Clinical development timelines accelerated for ABI-5366; now anticipating interim data from Phase 1a available in 3Q2024, initiation of Phase 1b in individuals with recurrent genital herpes by end of 2024 and interim Phase 1b data available in 1H2025Gilead Sciences, Inc. partnership supports advancement and strengthening of antiviral pipeline targeting serious viral diseases S

  • GlobeNewswire

    Assembly Biosciences Announces Effective Date of Reverse Stock Split

    – Assembly Bio common stock expected to begin trading on a split-adjusted basis on February 12, 2024 – SOUTH SAN FRANCISCO, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that it expects a 1-for-12 reverse stock split of its outstanding shares of common stock will be effective as of February 9, 2024. The company anticipates that its common s

  • Simply Wall St.

    This Assembly Biosciences Insider Increased Their Holding In The Last Year

    Looking at Assembly Biosciences, Inc.'s ( NASDAQ:ASMB ) insider transactions over the last year, we can see that...